CDC offers help in choosing a vaccine as flu season arrives
The flu season is upon us and now is the time to get your flu vaccine. “About 5% to 20% of the U.S. population […]
CDC offers help in choosing a vaccine as flu season arrives Read More »
The flu season is upon us and now is the time to get your flu vaccine. “About 5% to 20% of the U.S. population […]
CDC offers help in choosing a vaccine as flu season arrives Read More »
When the U.S. Department of Health and Human Services (HHS) follows the president’s instructions to find ways to reduce the cost of prescription drugs,
BIO experts say tackling PBMs would help reduce drug prices Read More »
The UN’s four key health and agriculture agencies today launched the first-ever One Health Joint Plan of Action, “a framework to integrate systems and
UN health, agriculture agencies launch One Health action plan Read More »
Moderna and Merck announced Wednesday they will cooperate and combine their technologies to develop jointly a personalized cancer vaccine (PCV) designed for people with
Moderna and Merck cooperate on personalized cancer vaccine Read More »
GSK on Thursday announced positive pivotal phase III trial results for its respiratory syncytial virus (RSV) vaccine candidate for adults aged 60 years and
RSV vaccine trial results from GSK show strong efficacy Read More »
The Taiwan Expo USA 2022 is underway in Washington D.C., and U.S.–Taiwan biotech partnership and innovation are on full display at the Taiwan Healthcare
US-Taiwan biotech innovation on full display at Taiwan Expo USA Read More »
The Omicron-focused Moderna and Pfizer-BioNTech COVID-19 vaccines were given emergency use authorization (EUA) by the Food and Drug Administration (FDA) yesterday for use as
FDA authorizes Omicron-focused boosters for kids Read More »
Various populations of vertebrates on the planet are declining at an alarming rate, according to the Living Planet Index, a biannual report that issued
Biodiversity in serious decline, biannual report finds Read More »
The global nonprofit partnership CARB-X (Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator) is focused on supporting antibacterial research. Last week, CARB-X opened a call for
CARB-X’s call for proposals seeks to fill gaps in the global AMR pipeline Read More »
“Boosting with updated mRNA vaccines that target SARS-CoV-2 variants stimulates better neutralizing antibody responses than homologous boosters,” emerging evidence shows, according to a recently
Updated mRNA boosters stimulate better neutralizing antibody responses Read More »